The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
“A novel feasible cure for demyelinating diseases?”: not yet but here is the concept
Preprint — published as 10.1016/j.msard.2021.103341 · Paper page
Abstract
Will the people with demyelinating diseases ever be able to use CAR Treg cells to be cured, if it proves effective in the future? Probably not, considering its gigantic price. Researchers should focus on developing an affordable safe Treg-specific viral vector to produce CAR Treg’s in-vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Metadata
- Authors
- Sedaghat, N., & Etemadifar, M.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Corresponding author
- Sedaghat, Nahad
- Venue
- Multiple Sclerosis and Related Disorders
- Publisher
- Wiley
- Published
- 2021-08-23
- Volume
- 57
- Pages
- 103341-103341
- ISSN
- 2211-0348 (ISSN-L)
- OpenAlex
- W3206819064
- Cited by
- 13
- References
- 1
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis and Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- chimeric antigen receptor, regulatory T cells, demyelinating disease, multiple sclerosis
- MeSH terms
- Receptors, Chimeric Antigen, Animals, Demyelinating Diseases, Humans, Receptors, Antigen, T-Cell, Immunotherapy, Adoptive, T-Lymphocytes, Regulatory, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: “A novel feasible cure for demyelinating diseases?”: not yet but here is the concept. https://app.cochat.ai/papers/10.22541/au.162912527.75500056/v5
- The paper
- Sedaghat, N., & Etemadifar, M. (2021). “A novel feasible cure for demyelinating diseases?”: not yet but here is the concept. Multiple Sclerosis and Related Disorders. https://doi.org/10.22541/au.162912527.75500056/v5
